Mesothelioma Treatment
Mesothelioma Cancer
- Causes of Mesothelioma
- Mesothelioma Symptoms
- Mesothelioma Diagnosis
- Mesothelioma Stages
- Mesothelioma Treatment
- Innovative Mesothelioma Treatments
- Managing Mesothelioma Pain
- Nutrition Information for Mesothelioma Patients
- Specialized Mesothelioma Care
- Mesothelioma Risks
- Mesothelioma Support Groups
- Find a Mesothelioma Attorney
- Mesothelioma News
Mesothelioma Directory
A Study To Find The Best Dose Of SU011248 When Given With Pemetrexed, Pemetrexed And Cisplatin Or Pemetrexed And Carboplatin In Patients With Advanced Solid Tumors
Get Help Today
Looking for help or additional information? Contact us today.| Conditions: | Mesothelioma|Non-small Cell Lung Cancer|Neoplasms |
| Start Date: | November 1, 2006 |
| Phase: | Phase I |
| Status: | Completed |
| NCT ID: | NCT00528619 |
| Study Type: | Interventional |
| Intervention: | Drug: Sunitinib, Pemetrexed, Cisplatin, Carboplatin |
| Study Design: | Allocation: Non-Randomized|Endpoint Classification: Safety/Efficacy Study|Intervention Model: Parallel Assignment|Masking: Open Label|Primary Purpose: Treatment |
| Results: | No Results Available |
| Sponsors: | Pfizer |
| Ages: | Adult|Senior |
| Enrollment: | 96 |
| Funded By: | Industry |
| First Received: | September 10, 2007 |
| End Date: | April 1, 2010 |
| Last Updated: | May 15, 2010 |
| Last Verified: | May 1, 2010 |